563 Episodes

  1. ALS Fight Carries Muller from Patient to Biotech CEO

    Published: 6/11/2015
  2. Examining the State of Sleep

    Published: 6/5/2015
  3. TheStreet’s Adam Feuerstein Previews ASCO 2015

    Published: 5/28/2015
  4. Home-Brew Morphine, Dual Use Technology, and the Biologist’s Repsonsibilities

    Published: 5/20/2015
  5. Reinventing Tech Transfer

    Published: 5/14/2015
  6. Thinking Narrowly About Antibiotics

    Published: 5/7/2015
  7. Promise Shown in Different Approach to Alzheimer’s

    Published: 4/30/2015
  8. Innovative Drugs Drive Big Increase in U.S. Spending

    Published: 4/23/2015
  9. Ensuring Digital Health Technologies Benefit Older People

    Published: 4/16/2015
  10. How the Sugar Industry Influenced Research to Protect Its Interests

    Published: 4/10/2015
  11. Examining The White House’s Plan to Combat Drug-Resistant Bacteria

    Published: 4/3/2015
  12. Weighing Adverse Events to Get at a Drug’s Real Costs

    Published: 3/26/2015
  13. How One Company Is Reinventing Drug Development

    Published: 3/19/2015
  14. Why Patent Trolling Threatens Biopharma

    Published: 3/13/2015
  15. Shifting Venture Investment Raises Concerns

    Published: 3/5/2015
  16. Will Policy Triumph Over Politics in 21st Century Cures Act

    Published: 2/26/2015
  17. Democratizing the World of Healthcare Analytics

    Published: 2/19/2015
  18. Will Funding for Obama’s Precision Medicine Initiative Match Its Ambition

    Published: 2/12/2015
  19. Should Investors Temper Their Enthusiasm for CAR-T Therapies

    Published: 2/5/2015
  20. What to Do About the United States’ Declining Investment in R&D

    Published: 1/29/2015

27 / 29

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.